Gao Y, Peng L, Liu J, Zhao C
Clin Rheumatol. 2025; 44(2):799-809.
PMID: 39808233
DOI: 10.1007/s10067-025-07321-2.
Lin Q, Wang Z, Ding G, Li G, Chen L, Qiu Q
Front Immunol. 2024; 15:1438640.
PMID: 39507528
PMC: 11537935.
DOI: 10.3389/fimmu.2024.1438640.
Jin Y, Geng Z, Lin K, Gu X, Feng X, Fu S
J Inflamm Res. 2024; 17:6193-6201.
PMID: 39281780
PMC: 11397173.
DOI: 10.2147/JIR.S468472.
Lombardi Pereira A, Aubuchon E, Moreira D, Lane M, Carvalho T, Mesquita T
Front Immunol. 2024; 15:1411979.
PMID: 38989288
PMC: 11234797.
DOI: 10.3389/fimmu.2024.1411979.
Xie Y, Shi H, Han B
BMC Pediatr. 2023; 23(1):90.
PMID: 36829193
PMC: 9951419.
DOI: 10.1186/s12887-023-03896-4.
Using bioinformatics analysis to screen abnormal methylated differentially expressed hub genes of Kawasaki disease and construct diagnostic model.
Sun H, Liu C, Zhang X, Liu P, Du Z, Luo G
Heliyon. 2022; 8(11):e11905.
PMID: 36458298
PMC: 9706175.
DOI: 10.1016/j.heliyon.2022.e11905.
G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1.
Okabe M, Takarada S, Miyao N, Nakaoka H, Ibuki K, Ozawa S
Pediatr Res. 2022; 92(2):378-387.
PMID: 35292727
PMC: 8922062.
DOI: 10.1038/s41390-022-01999-9.
Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease.
Choi I, Lee M, Choi S, Choi K, Jeong I, Cho H
Front Pediatr. 2022; 9:792870.
PMID: 35186822
PMC: 8855096.
DOI: 10.3389/fped.2021.792870.
Hygiene Hypothesis as the Etiology of Kawasaki Disease: Dysregulation of Early B Cell Development.
Lee J
Int J Mol Sci. 2021; 22(22).
PMID: 34830213
PMC: 8622879.
DOI: 10.3390/ijms222212334.
Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.
Wang Z, Xie L, Ding G, Song S, Chen L, Li G
Nat Commun. 2021; 12(1):5444.
PMID: 34521850
PMC: 8440575.
DOI: 10.1038/s41467-021-25771-5.
Epigenetics in Kawasaki Disease.
Sharma K, Vignesh P, Srivastava P, Sharma J, Chaudhary H, Mondal S
Front Pediatr. 2021; 9:673294.
PMID: 34249810
PMC: 8266996.
DOI: 10.3389/fped.2021.673294.
Long-Term Hypermethylation of in Leukocytes of Patients with Kawasaki Disease.
Chang L, Yu H, Chu C, Chen K, Huang Y, Guo M
J Clin Med. 2021; 10(11).
PMID: 34071896
PMC: 8199050.
DOI: 10.3390/jcm10112347.
The "Intermediate" CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease.
Kim Y, Yang H, Kee S, Choi I, Ha K, Ki K
Pediatr Rheumatol Online J. 2021; 19(1):76.
PMID: 34059085
PMC: 8165978.
DOI: 10.1186/s12969-021-00573-7.
Five immune-gene-signatures participate in the development and pathogenesis of Kawasaki disease.
Nie H, Wang S, Wu Q, Xue D, Zhou W
Immun Inflamm Dis. 2020; 9(1):157-166.
PMID: 33188570
PMC: 7860604.
DOI: 10.1002/iid3.373.
Association of an IGHV3-66 gene variant with Kawasaki disease.
Johnson T, Mashimo Y, Wu J, Yoon D, Hata A, Kubo M
J Hum Genet. 2020; 66(5):475-489.
PMID: 33106546
PMC: 7585995.
DOI: 10.1038/s10038-020-00864-z.
Insights Into Coronary Artery Lesions in Kawasaki Disease.
Zhang D, Liu L, Huang X, Tian J
Front Pediatr. 2020; 8:493.
PMID: 32984207
PMC: 7477115.
DOI: 10.3389/fped.2020.00493.
Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead.
Chaudhary H, Nameirakpam J, Kumrah R, Pandiarajan V, Suri D, Rawat A
Front Pediatr. 2019; 7:242.
PMID: 31275907
PMC: 6591436.
DOI: 10.3389/fped.2019.00242.
Innate immune responses following Kawasaki disease and toxic shock syndrome.
Chen K, Messina N, Germano S, Bonnici R, Freyne B, Cheung M
PLoS One. 2018; 13(2):e0191830.
PMID: 29447181
PMC: 5813928.
DOI: 10.1371/journal.pone.0191830.
Kawasaki disease: a matter of innate immunity.
Hara T, Nakashima Y, Sakai Y, Nishio H, Motomura Y, Yamasaki S
Clin Exp Immunol. 2016; 186(2):134-143.
PMID: 27342882
PMC: 5054572.
DOI: 10.1111/cei.12832.
Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.
Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F
J Med Virol. 2014; 86(12):2146-53.
PMID: 24760654
PMC: 7166330.
DOI: 10.1002/jmv.23950.